![](https://www.biopharmadive.com/imgproxy/PMT2Ok9O4pwlcz_jQVgLqVz6usrTw4wqd2J275X9I6c/g:ce/rs:fit:770:435/bG9jYWw6Ly8vZGl2ZWltYWdlL0JPU19IUV9leHRlcmlvcl9WZXJ0ZXguanBn.webp)
Vertex taps Orum to hunt for better ‘preconditioning’ drugs
Vertex Pharmaceuticals is exploring new ways to prepare patients for intensive therapies like its sickle cell treatment Casgevy, announcing Tuesday a deal with Orum Therapeutics to develop a different kind of conditioning regimen than the chemotherapies …